The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

被引：0
|
作者：
Carvalho, Julia [1 ]
Cupello, Mauricio [2 ]
Medina, Romulo [2 ]
机构：
[1] INCA, Rio De Janeiro, Brazil
[2] Unigranrio, Rio De Janeiro, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CAR-T; CRISPR/Cas9; Brazil; gene editing; universal CAR-T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-312
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [41] Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
    Rasul, Mohammed Fatih
    Hussen, Bashdar Mahmud
    Salihi, Abbas
    Ismael, Bnar Saleh
    Jalal, Paywast Jamal
    Zanichelli, Anna
    Jamali, Elena
    Baniahmad, Aria
    Ghafouri-Fard, Soudeh
    Basiri, Abbas
    Taheri, Mohammad
    MOLECULAR CANCER, 2022, 21 (01)
  • [42] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
    Cooper, Mathew L.
    DiPersio, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [43] Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
    Tbakhi, Bushra
    Reagan, Patrick M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [44] CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
    Selvakumar, Sushmaa Chandralekha
    Preethi, K. Auxzilia
    Ross, Kehinde
    Tusubira, Deusdedit
    Khan, Mohd Wajid Ali
    Mani, Panagal
    Rao, Tentu Nageswara
    Sekar, Durairaj
    MOLECULAR CANCER, 2022, 21 (01)
  • [45] CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
    Sushmaa Chandralekha Selvakumar
    K. Auxzilia Preethi
    Kehinde Ross
    Deusdedit Tusubira
    Mohd Wajid Ali Khan
    Panagal Mani
    Tentu Nageswara Rao
    Durairaj Sekar
    Molecular Cancer, 21
  • [46] Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond
    Mirza, Zeenat
    Karim, Sajjad
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2019, 96 : 13 - 21
  • [47] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
    Paula Salmikangas
    Niamh Kinsella
    Paul Chamberlain
    Pharmaceutical Research, 2018, 35
  • [48] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
    Salmikangas, Paula
    Kinsella, Niamh
    Chamberlain, Paul
    PHARMACEUTICAL RESEARCH, 2018, 35 (08)
  • [49] How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
    Johansen, Kristoffer Haurum
    DNA AND CELL BIOLOGY, 2022, 41 (01) : 53 - 57
  • [50] Emerging CRISPR/Cas9 applications for T-cell gene editing
    Preece, Roland
    Georgiadis, Christos
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 261 - 275
12345